Donna Hudson is CURE’s Vice President of Quality and Compliance Systems. Ms. Hudson is responsible for all strategic tactical matters as they relate to quality management and key compliance requirements. Donna’s background includes 20+ years in quality engineering and compliance in the aerospace, defense, and biotechnology industries. Prior to joining CURE Pharmaceutical in 2019, Ms. Hudson served in leadership roles at HRL Labs, LLC, owned by Boeing and General Motors, for 7+ years, in both Quality and Operations Management. She was responsible for standing up a new company wide quality department, development of new processes, companywide quality auditing, maintaining certification with government and regulatory compliance, multi-department management, process measurement, analysis, and improvement. She has also held key quality positions at Amgen and ICOS Corporations. Donna has proven business operations skills in project management as well as directing, supervising, and training cross functional collaborations. She has been a key contributor in the development and commercialization of various drug technologies as well as government funded aerospace and defense projects and is a strong supporter of implementing continual improvement as a tool for advancing business success. Ms. Hudson received her B.A. in Communications with a concentration in Business from California Lutheran University, Thousand Oaks, CA.